The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $2,250,000 Project Grant under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997) to the Dallas County Mental Health & Mental Retardation Center, doing business as Dallas Metrocare Services. The grant will fund the implementation of an AOT program for adults with severe mental illness in Dallas County, Texas over a 4-year period from September 2024 to September 2028. The AOT program will provide...
The South Central Louisiana Human Services Authority (SCLHSA) was awarded a $1,050,669 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997). The grant will enable SCLHSA, in partnership with the 32nd Judicial District Court and Terrebonne Parish stakeholders, to create, implement, and evaluate the first AOT program in the SCLHSA region. Additionally, SCLHSA will establish an Assertive...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,500,000 Project Grant (CFDA 93.997 - Assisted Outpatient Treatment Program) to SMA Healthcare, Inc. to develop and implement an Assisted Outpatient Treatment (AOT) program serving the residents of St. Johns, Flagler, and Putnam Counties in Florida. The grant will fund 3 targeted case managers and 3 recovery support specialists to identify and engage 220 individuals with serious mental illness who have a history...
This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997) will provide $2,997,948 over four years to the Denton County Mhmr Center in Texas. The grant will fund the Assisted Outpatient Treatment Project (AOTP) to serve at least 300 court-mandated residents of Denton County who have serious mental illness and/or serious emotional disturbance and experience rapid re-hospitalization and...
The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $3,000,000 Project Grant under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997) to Region IV Mental Health, a state-level public behavioral health authority in Mississippi. The grant will support the implementation, evaluation, and sustainability of an Assisted Outpatient Treatment program targeting adults aged 18 and older with serious mental illness (SMI) who meet criteria for court-ordered...
The federal Project Grant award H79SM089821 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997). The $1,500,000 grant will fund a 4-year project by Cascade Community Healthcare, a non-profit healthcare organization in Centralia, Washington, to provide court-ordered outpatient treatment for adults with serious mental illness (SMI), serious emotional disturbance (SED), and substance use or...
The U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $2,249,157 Project Grant under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997) to the Hillcrest Children and Family Center in Washington, DC. The four-year grant will support the implementation of the Hillcrest AOT Project, which aims to provide comprehensive mental health services to adults with severe mental illness (SMI), including those with...
The Hays County Assisted Outpatient Treatment Program is a $1,357,959 Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the federal Assisted Outpatient Treatment (AOT) Program (CFDA 93.997). The 4-year grant, effective September 30, 2024, will support the establishment of an AOT program in Hays County, Texas to serve adults with serious mental illness, including those with co-occurring substance use disorders. Over the course of the grant...
The Montgomery Area Mental Health Authority, Inc., doing business as Mental Health Center, was awarded a $3,000,000 Project Grant by the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997). The grant will fund the implementation of the Carastar Health Assisted Outpatient Treatment Program for individuals with serious mental illness in Montgomery, Alabama. The program...
The Guam Behavioral Health & Wellness Center (GBHWC) was awarded a $1,500,000 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997). The grant will fund the implementation of court-ordered outpatient treatment strategies to support adults with serious mental illness (SMI) in Guam who are unlikely to voluntarily participate in treatment that would enable them to live safely in the...
The Gulf Coast Center will use this $1,498,500 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Assisted Outpatient Treatment (AOT) Program (CFDA 93.997) to reduce psychiatric hospitalizations, emergency healthcare service usage, homelessness, and incarceration for adults aged 18 and older with serious mental illness (SMI) in Galveston and Brazoria Counties, Texas. Over the 4-year project period, the Gulf Coast Center and its community partners (Sun Behavioral Health, Galveston County Probate Court, and Galveston County Mental Health Court) will serve 125 uninsured/underinsured English and Spanish-speaking residents with SMI who have demonstrated significant barriers to sustained voluntary treatment engagement. The program will provide individualized, evidence-based trauma-informed services such as case management, psychotherapy, psychosocial rehabilitation, supported employment, and medication management. An independent evaluation team will assess the program's implementation and outcomes to ensure it meets participants' needs, complies with state laws, and achieves its goals of improving treatment adherence and functional outcomes, thereby decreasing the taxpayer burden associated with repeated justice system involvement and emergency healthcare usage.